- Home
- ZIP vs BCYC Comparison
ZIP vs BCYC Comparison
Compare ZIP & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZIP
- BCYC
- Stock Information
- Founded
- ZIP 2010
- BCYC 2009
- Country
- ZIP United States
- BCYC United Kingdom
- Employees
- ZIP N/A
- BCYC N/A
- Industry
- ZIP Diversified Commercial Services
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- ZIP Consumer Discretionary
- BCYC Health Care
- Exchange
- ZIP Nasdaq
- BCYC Nasdaq
- Market Cap
- ZIP 784.5M
- BCYC 896.2M
- IPO Year
- ZIP 2021
- BCYC 2019
- Fundamental
- Price
- ZIP $6.96
- BCYC $11.66
- Analyst Decision
- ZIP Hold
- BCYC Buy
- Analyst Count
- ZIP 6
- BCYC 9
- Target Price
- ZIP $9.80
- BCYC $33.25
- AVG Volume (30 Days)
- ZIP 464.2K
- BCYC 295.8K
- Earning Date
- ZIP 02-25-2025
- BCYC 03-04-2025
- Dividend Yield
- ZIP N/A
- BCYC N/A
- EPS Growth
- ZIP N/A
- BCYC N/A
- EPS
- ZIP 0.03
- BCYC N/A
- Revenue
- ZIP $498,903,000.00
- BCYC $36,898,000.00
- Revenue This Year
- ZIP N/A
- BCYC $41.07
- Revenue Next Year
- ZIP N/A
- BCYC N/A
- P/E Ratio
- ZIP $236.57
- BCYC N/A
- Revenue Growth
- ZIP N/A
- BCYC 48.60
- 52 Week Low
- ZIP $6.51
- BCYC $11.14
- 52 Week High
- ZIP $13.03
- BCYC $28.67
- Technical
- Relative Strength Index (RSI)
- ZIP 38.68
- BCYC 34.58
- Support Level
- ZIP $7.15
- BCYC $11.14
- Resistance Level
- ZIP $8.00
- BCYC $13.11
- Average True Range (ATR)
- ZIP 0.34
- BCYC 0.69
- MACD
- ZIP -0.05
- BCYC 0.08
- Stochastic Oscillator
- ZIP 19.56
- BCYC 22.32
About ZIP ZipRecruiter Inc.
ZipRecruiter Inc is an online employment marketplace. It was founded to make meaningful connections between job seekers and employers. It connects millions of job seekers with companies of all sizes. It is a two-sided marketplace for work that simplifies the job market for both job seekers and employers. Unlike traditional online job sites, ZipRecruiter works like a matchmaker curating job opportunities for job seekers, and candidates for employers.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.